Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP871277.RAcH4r9Gc9AYTCMd-9SFNaLrB915Lj8w3rZsJOktuR-p4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP871277.RAcH4r9Gc9AYTCMd-9SFNaLrB915Lj8w3rZsJOktuR-p4130_assertion type Assertion NP871277.RAcH4r9Gc9AYTCMd-9SFNaLrB915Lj8w3rZsJOktuR-p4130_head.
- NP871277.RAcH4r9Gc9AYTCMd-9SFNaLrB915Lj8w3rZsJOktuR-p4130_assertion description "[KRAS mutations were infrequently identified in gallbladder carcinoma (2/29, 7%) and high-grade dysplastic lesions (0/5, 0%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP871277.RAcH4r9Gc9AYTCMd-9SFNaLrB915Lj8w3rZsJOktuR-p4130_provenance.
- NP871277.RAcH4r9Gc9AYTCMd-9SFNaLrB915Lj8w3rZsJOktuR-p4130_assertion evidence source_evidence_literature NP871277.RAcH4r9Gc9AYTCMd-9SFNaLrB915Lj8w3rZsJOktuR-p4130_provenance.
- NP871277.RAcH4r9Gc9AYTCMd-9SFNaLrB915Lj8w3rZsJOktuR-p4130_assertion SIO_000772 21307665 NP871277.RAcH4r9Gc9AYTCMd-9SFNaLrB915Lj8w3rZsJOktuR-p4130_provenance.
- NP871277.RAcH4r9Gc9AYTCMd-9SFNaLrB915Lj8w3rZsJOktuR-p4130_assertion wasDerivedFrom befree-2016 NP871277.RAcH4r9Gc9AYTCMd-9SFNaLrB915Lj8w3rZsJOktuR-p4130_provenance.
- NP871277.RAcH4r9Gc9AYTCMd-9SFNaLrB915Lj8w3rZsJOktuR-p4130_assertion wasGeneratedBy ECO_0000203 NP871277.RAcH4r9Gc9AYTCMd-9SFNaLrB915Lj8w3rZsJOktuR-p4130_provenance.